GB1463575A - Vinca alkaloid derivatives - Google Patents

Vinca alkaloid derivatives

Info

Publication number
GB1463575A
GB1463575A GB1310174A GB1310174A GB1463575A GB 1463575 A GB1463575 A GB 1463575A GB 1310174 A GB1310174 A GB 1310174A GB 1310174 A GB1310174 A GB 1310174A GB 1463575 A GB1463575 A GB 1463575A
Authority
GB
United Kingdom
Prior art keywords
hydrogen
formula
compound
alkanoyl
chloroalkanoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1310174A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of GB1463575A publication Critical patent/GB1463575A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1463575 Novel amides, azides and hydrazides of vinca alkaloids ELI LILLY & CO 25 March 1974 [2 April 1973] 13101/74 Heading C2C Novel compounds of the Formula I wherein R is NH 2 , NH.NH 2 , N(CH 3 ) 3 , NHalk-X, NH(C 3-8 )cycloalkyl, NHalkAm, NHalk(OH) 1-3 or N 3 ; wherein alk is C 1-6 alkylene, Am is NH 2 , NHCH 3 or N(CH 3 ) 2 , X is hydrogen, CN, optionally substituted phenyl, carboxy, carbo- (C 1-3 )-alkoxy, or carboxamido; R<SP>1</SP> is H, alkanoyl or chloroalkanoyl; R<SP>11</SP> is hydrogen, C 1-3 alkyl, formyl or alkanoyl; and one of R<SP>111</SP> and R<SP>1111</SP> is hydroxy and the other is ethyl, in which alkanoyl groups have 1-3 carbon atoms in the alkane moiety, and salts thereof, may be prepared by reacting a compound of the Formula I wherein R is OCH 3 , R<SP>1</SP> is hydrogen or acetyl and R<SP>11</SP>, R<SP>111</SP> and R<SP>1111</SP> are as defined above with ammonia, methylamine or hydrazine to obtain a compound of Formula I wherein R is NH 2 , NHCH 3 or NH.NH 2 , and R<SP>1</SP> is hydrogen and, if desired, when R is NHNH 2 (a) reacting said compound with a nitrosating agent to form an azide in where R 3 N 3 and then reacting said azide with ammonia, an amine of the formula HN(CH 3 ) 2 , NH 2 alk-X, NH 2 -(C 3-8 )cycloalkyl, NH 2 alkAm or NH 2 alk(OH) 1-3 to obtain the corresponding compound of Formula I or (b) hydrogenolysing said compound with Raney nickel in an inert solvent to yield a compound of the Formula I wherein R is NH 2 , and/or, if desired, acylating a product in which R<SP>1</SP> is hydrogen to introduce an alkanoyl or chloroalkanoyl group at R<SP>1</SP>, and, if in the starting material R<SP>11</SP> is hydrogen, to introduce an alkanoyl or chloroalkanoyl at R<SP>11</SP>. Various by-products having the same ring systems as I are formed during some of the above reactions. Pharmaceutical compositions of the compounds I or salts thereof with the usual excipients may be administered orally or parenterally for treating neoplastic disease. The compounds also show antivral activity in vitro against herpes virus.
GB1310174A 1973-04-02 1974-03-25 Vinca alkaloid derivatives Expired GB1463575A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34727573A 1973-04-02 1973-04-02

Publications (1)

Publication Number Publication Date
GB1463575A true GB1463575A (en) 1977-02-02

Family

ID=23363051

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1310174A Expired GB1463575A (en) 1973-04-02 1974-03-25 Vinca alkaloid derivatives

Country Status (28)

Country Link
JP (2) JPS5919117B2 (en)
AR (2) AR204004A1 (en)
AT (1) AT340605B (en)
BE (1) BE813168A (en)
BG (3) BG21612A3 (en)
CA (1) CA1042428A (en)
CH (1) CH603669A5 (en)
CS (1) CS185223B2 (en)
CY (1) CY1044A (en)
DD (1) DD113538A5 (en)
DE (1) DE2415980A1 (en)
DK (1) DK141511B (en)
ES (2) ES424882A1 (en)
FR (1) FR2223044B1 (en)
GB (1) GB1463575A (en)
HK (1) HK20180A (en)
HU (1) HU171572B (en)
IE (1) IE39071B1 (en)
IL (1) IL44415A (en)
KE (1) KE3028A (en)
MY (1) MY8100025A (en)
NL (1) NL181079C (en)
PH (1) PH13623A (en)
RO (2) RO77533A (en)
SE (1) SE416206B (en)
SU (4) SU731900A3 (en)
YU (3) YU39719B (en)
ZA (1) ZA741674B (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2438052A1 (en) * 1978-05-15 1980-04-30 Lilly Co Eli NOVEL PROCESS FOR THE PREPARATION OF BRIDGE DIMERES OF CATHARANTHUS ALKALOIDS AND INTERMEDIATE COMPOUNDS
WO1996031518A1 (en) * 1995-04-04 1996-10-10 MTA Enzimológiai Intézet Novel tumor-inhibiting bisindole derivatives with calmodulin-liberator effect and pharmaceutical composition containing them
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US7732491B2 (en) 2007-11-12 2010-06-08 Bipar Sciences, Inc. Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
US7994222B2 (en) 2006-09-05 2011-08-09 Bipar Sciences, Inc. Monitoring of the inhibition of fatty acid synthesis by iodo-nitrobenzamide compounds
US8143447B2 (en) 2006-09-05 2012-03-27 Bipar Sciences, Inc. Treatment of cancer
US8377985B2 (en) 2005-07-18 2013-02-19 Bipar Sciences, Inc. Treatment of cancer
CN105121447A (en) * 2013-04-19 2015-12-02 暨南大学 Vinblastine derivatives, preparation method therefor and application thereof
CN113456797A (en) * 2021-06-18 2021-10-01 暨南大学 Application of vinblastine derivative in preparation of medicine for treating osteosarcoma and/or soft tissue sarcoma

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48685A (en) * 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
GR69783B (en) * 1976-09-08 1982-07-07 Lilly Co Eli
US4096148A (en) * 1976-12-06 1978-06-20 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30560E (en) * 1976-12-06 1981-03-31 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30561E (en) 1976-12-06 1981-03-31 Eli Lilly And Company Vinca alkaloid intermediates
US4203898A (en) 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4357334A (en) 1980-03-20 1982-11-02 Eli Lilly And Company Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms
LU83822A1 (en) * 1981-12-08 1983-09-01 Omnichem Sa N- (VINBLASTINOYL-23) DERIVATIVES OF AMINO ACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
OA06421A (en) * 1980-06-10 1981-09-30 Omnium Chimique Sa Process for the preparation of N- (vinblastinoyl-23) derivatives of amino acids and peptides.
FR2623504B1 (en) * 1987-11-25 1990-03-09 Adir NOVEL N- (VINBLASTINOYL-23) DERIVATIVES OF 1-AMINO METHYLPHOSPHONIC ACID, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US6326402B1 (en) 1998-08-12 2001-12-04 Octamer, Inc. Methods for treating viral infections using a compound capable of inhibiting microtubules
JP5475234B2 (en) 2005-01-21 2014-04-16 アステックス・セラピューティクス・リミテッド Pharmaceutical compounds
JP5528806B2 (en) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド Compound drug
JP5528807B2 (en) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド Compound drug

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2438052A1 (en) * 1978-05-15 1980-04-30 Lilly Co Eli NOVEL PROCESS FOR THE PREPARATION OF BRIDGE DIMERES OF CATHARANTHUS ALKALOIDS AND INTERMEDIATE COMPOUNDS
EP0032756A2 (en) * 1978-05-15 1981-07-29 Eli Lilly And Company Intermediates used in the preparation of bridged catharanthus alkaloid dimers
EP0033981A2 (en) * 1978-05-15 1981-08-19 Eli Lilly And Company Preparation of bridged catharanthus alkaloid dimers
EP0033981A3 (en) * 1978-05-15 1981-09-09 Eli Lilly And Company Preparation of bridged catharanthus alkaloid dimers
EP0032756A3 (en) * 1978-05-15 1981-09-09 Eli Lilly And Company Intermediates used in the preparation of bridged catharanthus alkaloid dimers
WO1996031518A1 (en) * 1995-04-04 1996-10-10 MTA Enzimológiai Intézet Novel tumor-inhibiting bisindole derivatives with calmodulin-liberator effect and pharmaceutical composition containing them
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US8377985B2 (en) 2005-07-18 2013-02-19 Bipar Sciences, Inc. Treatment of cancer
US7994222B2 (en) 2006-09-05 2011-08-09 Bipar Sciences, Inc. Monitoring of the inhibition of fatty acid synthesis by iodo-nitrobenzamide compounds
US8143447B2 (en) 2006-09-05 2012-03-27 Bipar Sciences, Inc. Treatment of cancer
US7732491B2 (en) 2007-11-12 2010-06-08 Bipar Sciences, Inc. Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
CN105121447A (en) * 2013-04-19 2015-12-02 暨南大学 Vinblastine derivatives, preparation method therefor and application thereof
EP2987794A4 (en) * 2013-04-19 2016-11-30 Univ Jinan Vinblastine derivatives, preparation method therefor and application thereof
AU2014253584B2 (en) * 2013-04-19 2017-02-02 Jinan University Vinca Alkaloid Derivatives, Preparation Method therefor and Application thereof
CN105121447B (en) * 2013-04-19 2018-02-02 暨南大学 Vinca derivative and its preparation method and application
CN113456797A (en) * 2021-06-18 2021-10-01 暨南大学 Application of vinblastine derivative in preparation of medicine for treating osteosarcoma and/or soft tissue sarcoma
CN113456797B (en) * 2021-06-18 2024-03-08 暨南大学 Application of vinblastine derivatives in preparation of medicines for treating osteosarcoma and/or soft tissue sarcoma

Also Published As

Publication number Publication date
SU784783A3 (en) 1980-11-30
YU39876B (en) 1985-04-30
YU39875B (en) 1985-04-30
CS185223B2 (en) 1978-09-15
DK141511C (en) 1980-09-29
IE39071L (en) 1974-10-02
DK141511B (en) 1980-04-08
RO73524A (en) 1984-10-31
AR203882A1 (en) 1975-10-31
IL44415A0 (en) 1974-06-30
SU652896A3 (en) 1979-03-15
AT340605B (en) 1977-12-27
FR2223044A1 (en) 1974-10-25
SU623522A3 (en) 1978-09-05
DD113538A5 (en) 1975-06-12
AR204004A1 (en) 1975-11-12
CA1042428A (en) 1978-11-14
YU113980A (en) 1982-05-31
CY1044A (en) 1980-08-01
BG21235A3 (en) 1976-03-20
DE2415980C2 (en) 1989-11-09
IL44415A (en) 1978-08-31
BG22831A3 (en) 1977-04-20
HU171572B (en) 1978-02-28
JPS6033837B2 (en) 1985-08-05
ES424882A1 (en) 1976-12-16
JPS5919117B2 (en) 1984-05-02
RO77533A (en) 1982-02-01
SU731900A3 (en) 1980-04-30
CH603669A5 (en) 1978-08-31
BG21612A3 (en) 1976-07-20
ZA741674B (en) 1975-10-29
HK20180A (en) 1980-04-25
ATA267974A (en) 1977-04-15
MY8100025A (en) 1981-12-31
AU6671974A (en) 1975-09-18
NL181079C (en) 1987-06-16
IE39071B1 (en) 1978-08-02
FR2223044B1 (en) 1978-06-30
JPS59193895A (en) 1984-11-02
SE416206B (en) 1980-12-08
DE2415980A1 (en) 1974-10-10
ES446571A1 (en) 1977-06-16
KE3028A (en) 1980-03-28
NL7404423A (en) 1974-10-04
JPS49128000A (en) 1974-12-07
PH13623A (en) 1980-08-07
YU39719B (en) 1985-04-30
NL181079B (en) 1987-01-16
BE813168A (en) 1974-10-02
YU81774A (en) 1982-05-31
RO73524B (en) 1984-11-30
YU113880A (en) 1982-05-31

Similar Documents

Publication Publication Date Title
GB1463575A (en) Vinca alkaloid derivatives
ES8207508A1 (en) Mannich-base hydroxamic acid prodrugs for the improved bioavailability of non-steroidal anti-inflammatory agents, a process for preparing and a pharmaceutical composition containing them.
US5366992A (en) Benzoic acid substituted derivatives having cardiovascular activity
GB1447599A (en) Derivatives of alpha-methyldopa
IE811830L (en) Indoles.
ES431454A1 (en) Novel 1-phthalazone derivative, a process for its preparation and a pharmaceutical composition containing it
GB1535967A (en) Antilipidemic para-(aryl(alkyl or alkenyl)-amino)-benzoic acid derivatives
GB1212460A (en) Naphthacene derivatives
US3458528A (en) Nitroimidazole carbonates and thionocarbonates
GB1507709A (en) Benz(de)isoquinoline derivatives
GB1492622A (en) Aralkyl esters of amino alkanoic acids
GB1420067A (en) Aryldiamides
GB1340898A (en) Substituted oxazepines and pharmaceutical preparations containing same
GB1059175A (en) Heterocyclic compounds which have pharmacodynamic activity and/or which are intermediates in the preparation of products having pharmacodynamic activity
GB1461667A (en) Amphetamine derivatives
GB1380145A (en) Acetamidine derivatives process for preparing the same and pharma ceutical uses thereof
GB1429571A (en) 4-aryl-5-aminoalkyl-4-oxazolin-2ones
GB1492234A (en) Xanthene-9-carboxylates and a process for the preparation thereof
ES453664A1 (en) 5-Amino or substituted amino-7-phenyl or substituted phenyl-2,3-dihydro-1H-1,4-diazepines
US3325495A (en) Purine carboxamides
GB1453910A (en) Benzazepine derivatives
GB1324687A (en) 3-amino-delta2-pyrazoline derivatives and process for the preparation thereof
GB1464109A (en) Antibacterial acylaminoquinoxaline carboxamide 1,4-dioxides
GB1508222A (en) Derivatives of pyrazolopyridines
GB1446833A (en) Hydroxamic acid derivatives of substituted a-aminooxycarboxylic acids and a process for the preparation thereof

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
704A Declaration that licence is not available as of right for an excepted use (par. 4a/1977)
PE20 Patent expired after termination of 20 years

Effective date: 19940324